Genomic characterization of Burkholderia pseudomallei isolates selected for medical countermeasures testing: Comparative genomics associated with differential virulence

Jason W. Sahl, Christopher J. Allender, Rebecca E. Colman, Katy J. Califf, James M. Schupp, Bart J. Currie, Kristopher E. Van Zandt, H. Carl Gelhaus, Paul S Keim, Apichai Tuanyok

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Burkholderia pseudomallei is the causative agent of melioidosis and a potential bioterrorism agent. In the development of medical countermeasures against B. pseudomallei infection, the US Food and Drug Administration (FDA) animal Rule recommends using well-characterized strains in animal challenge studies. In this study, whole genome sequence data were generated for 6 B. pseudomallei isolates previously identified as candidates for animal challenge studies; an additional 5 isolates were sequenced that were associated with human inhalational melioidosis. A core genome single nucleotide polymorphism (SNP) phylogeny inferred from a concatenated SNP alignment from the 11 isolates sequenced in this study and a diverse global collection of isolates demonstrated the diversity of the proposed Animal Rule isolates. To understand the genomic composition of each isolate, a large-scale blast score ratio (LS-BSR) analysis was performed on the entire pan-genome; this demonstrated the variable composition of genes across the panel and also helped to identify genes unique to individual isolates. In addition, a set of ~550 genes associated with pathogenesis in B. pseudomallei were screened against the 11 sequenced genomes with LSBSR. Differential gene distribution for 54 virulence-associated genes was observed between genomes and three of these genes were correlated with differential virulence observed in animal challenge studies using BALB/c mice. Differentially conserved genes and SNPs associated with disease severity were identified and could be the basis for future studies investigating the pathogenesis of B. pseudomallei. Overall, the genetic characterization of the 11 proposed Animal Rule isolates provides context for future studies involving B. pseudomallei pathogenesis, differential virulence, and efficacy to therapeutics.

Original languageEnglish (US)
Article numbere0121052
JournalPLoS One
Volume10
Issue number3
DOIs
StatePublished - Mar 24 2015

Fingerprint

Burkholderia pseudomallei
Genomics
Virulence
virulence
Genes
genomics
Testing
Genome
genome
Animals
Melioidosis
genes
Single Nucleotide Polymorphism
testing
animals
pathogenesis
single nucleotide polymorphism
Burkholderia Infections
Biological Warfare Agents
bioterrorism

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Genomic characterization of Burkholderia pseudomallei isolates selected for medical countermeasures testing : Comparative genomics associated with differential virulence. / Sahl, Jason W.; Allender, Christopher J.; Colman, Rebecca E.; Califf, Katy J.; Schupp, James M.; Currie, Bart J.; Van Zandt, Kristopher E.; Gelhaus, H. Carl; Keim, Paul S; Tuanyok, Apichai.

In: PLoS One, Vol. 10, No. 3, e0121052, 24.03.2015.

Research output: Contribution to journalArticle

Sahl, Jason W. ; Allender, Christopher J. ; Colman, Rebecca E. ; Califf, Katy J. ; Schupp, James M. ; Currie, Bart J. ; Van Zandt, Kristopher E. ; Gelhaus, H. Carl ; Keim, Paul S ; Tuanyok, Apichai. / Genomic characterization of Burkholderia pseudomallei isolates selected for medical countermeasures testing : Comparative genomics associated with differential virulence. In: PLoS One. 2015 ; Vol. 10, No. 3.
@article{dcffe6ef270644fea58344feab9bedc3,
title = "Genomic characterization of Burkholderia pseudomallei isolates selected for medical countermeasures testing: Comparative genomics associated with differential virulence",
abstract = "Burkholderia pseudomallei is the causative agent of melioidosis and a potential bioterrorism agent. In the development of medical countermeasures against B. pseudomallei infection, the US Food and Drug Administration (FDA) animal Rule recommends using well-characterized strains in animal challenge studies. In this study, whole genome sequence data were generated for 6 B. pseudomallei isolates previously identified as candidates for animal challenge studies; an additional 5 isolates were sequenced that were associated with human inhalational melioidosis. A core genome single nucleotide polymorphism (SNP) phylogeny inferred from a concatenated SNP alignment from the 11 isolates sequenced in this study and a diverse global collection of isolates demonstrated the diversity of the proposed Animal Rule isolates. To understand the genomic composition of each isolate, a large-scale blast score ratio (LS-BSR) analysis was performed on the entire pan-genome; this demonstrated the variable composition of genes across the panel and also helped to identify genes unique to individual isolates. In addition, a set of ~550 genes associated with pathogenesis in B. pseudomallei were screened against the 11 sequenced genomes with LSBSR. Differential gene distribution for 54 virulence-associated genes was observed between genomes and three of these genes were correlated with differential virulence observed in animal challenge studies using BALB/c mice. Differentially conserved genes and SNPs associated with disease severity were identified and could be the basis for future studies investigating the pathogenesis of B. pseudomallei. Overall, the genetic characterization of the 11 proposed Animal Rule isolates provides context for future studies involving B. pseudomallei pathogenesis, differential virulence, and efficacy to therapeutics.",
author = "Sahl, {Jason W.} and Allender, {Christopher J.} and Colman, {Rebecca E.} and Califf, {Katy J.} and Schupp, {James M.} and Currie, {Bart J.} and {Van Zandt}, {Kristopher E.} and Gelhaus, {H. Carl} and Keim, {Paul S} and Apichai Tuanyok",
year = "2015",
month = "3",
day = "24",
doi = "10.1371/journal.pone.0121052",
language = "English (US)",
volume = "10",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "3",

}

TY - JOUR

T1 - Genomic characterization of Burkholderia pseudomallei isolates selected for medical countermeasures testing

T2 - Comparative genomics associated with differential virulence

AU - Sahl, Jason W.

AU - Allender, Christopher J.

AU - Colman, Rebecca E.

AU - Califf, Katy J.

AU - Schupp, James M.

AU - Currie, Bart J.

AU - Van Zandt, Kristopher E.

AU - Gelhaus, H. Carl

AU - Keim, Paul S

AU - Tuanyok, Apichai

PY - 2015/3/24

Y1 - 2015/3/24

N2 - Burkholderia pseudomallei is the causative agent of melioidosis and a potential bioterrorism agent. In the development of medical countermeasures against B. pseudomallei infection, the US Food and Drug Administration (FDA) animal Rule recommends using well-characterized strains in animal challenge studies. In this study, whole genome sequence data were generated for 6 B. pseudomallei isolates previously identified as candidates for animal challenge studies; an additional 5 isolates were sequenced that were associated with human inhalational melioidosis. A core genome single nucleotide polymorphism (SNP) phylogeny inferred from a concatenated SNP alignment from the 11 isolates sequenced in this study and a diverse global collection of isolates demonstrated the diversity of the proposed Animal Rule isolates. To understand the genomic composition of each isolate, a large-scale blast score ratio (LS-BSR) analysis was performed on the entire pan-genome; this demonstrated the variable composition of genes across the panel and also helped to identify genes unique to individual isolates. In addition, a set of ~550 genes associated with pathogenesis in B. pseudomallei were screened against the 11 sequenced genomes with LSBSR. Differential gene distribution for 54 virulence-associated genes was observed between genomes and three of these genes were correlated with differential virulence observed in animal challenge studies using BALB/c mice. Differentially conserved genes and SNPs associated with disease severity were identified and could be the basis for future studies investigating the pathogenesis of B. pseudomallei. Overall, the genetic characterization of the 11 proposed Animal Rule isolates provides context for future studies involving B. pseudomallei pathogenesis, differential virulence, and efficacy to therapeutics.

AB - Burkholderia pseudomallei is the causative agent of melioidosis and a potential bioterrorism agent. In the development of medical countermeasures against B. pseudomallei infection, the US Food and Drug Administration (FDA) animal Rule recommends using well-characterized strains in animal challenge studies. In this study, whole genome sequence data were generated for 6 B. pseudomallei isolates previously identified as candidates for animal challenge studies; an additional 5 isolates were sequenced that were associated with human inhalational melioidosis. A core genome single nucleotide polymorphism (SNP) phylogeny inferred from a concatenated SNP alignment from the 11 isolates sequenced in this study and a diverse global collection of isolates demonstrated the diversity of the proposed Animal Rule isolates. To understand the genomic composition of each isolate, a large-scale blast score ratio (LS-BSR) analysis was performed on the entire pan-genome; this demonstrated the variable composition of genes across the panel and also helped to identify genes unique to individual isolates. In addition, a set of ~550 genes associated with pathogenesis in B. pseudomallei were screened against the 11 sequenced genomes with LSBSR. Differential gene distribution for 54 virulence-associated genes was observed between genomes and three of these genes were correlated with differential virulence observed in animal challenge studies using BALB/c mice. Differentially conserved genes and SNPs associated with disease severity were identified and could be the basis for future studies investigating the pathogenesis of B. pseudomallei. Overall, the genetic characterization of the 11 proposed Animal Rule isolates provides context for future studies involving B. pseudomallei pathogenesis, differential virulence, and efficacy to therapeutics.

UR - http://www.scopus.com/inward/record.url?scp=84925865074&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925865074&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0121052

DO - 10.1371/journal.pone.0121052

M3 - Article

C2 - 25803742

AN - SCOPUS:84925865074

VL - 10

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 3

M1 - e0121052

ER -